Three days of pure value
Conference Schedule
Day one
WEDNESDAY 12TH
7:20 am
7.20 Check In & Morning Coffee
8:20 am
Chair’s Opening Remarks
8:21 am
Visions for the Future of mRNA & Beyond: The Leadership Perspective
9:15 am
Current Cancer Vaccine Strategies Including Initial Phase 1 Study Data of CVGBM, an Off-the-Shelf Cancer Vaccine in Glioblastoma
10:15 am
10:15 Morning Break & Speed Networking
10:58 am
TRACK A: DISCOVERY & PRE-CLINICAL DEVELOPMENT
10:59 am
Deciphering a Regulatory Framework & Guidance for Future mRNA Platforms to Harmonise Clinical & Manufacturing Development
11:15 am
The Value of a Harmonised Regulatory Framework for mRNA Medicines
12:15 pm
Harnessing In Vivo Therapeutic Antibody Production Enabled by mRNA-LNP Technology
12:15 pm
Swiss Regulatory Aspects & Evaluation for mRNABased Vaccines & Therapeutic Pathways to Approval
12:45 pm
Session Reserved for: Tebu Bio
12:45 pm
Session Reserved for: Arcalis
12:55 pm
12.55 Lunch Break & Networking
1:29 pm
Turbocharging new mRNA-LNP Programs to Expand Therapeutic Potential with European Research Initiatives & Collaborations
1:29 pm
Forging New Commercial Partnerships to Ensure Smooth Transfer into Trials & Manufacturing at Scale
2:00 pm
REGeRNA Project: Identifying & Developing mRNAEncoded Proteins Towards Novel Therapeutics for Cardiac Tissue Regeneration
2:30 pm
Multidimensional Characterisation of RNA-Based Vaccines & Therapies
4:00 pm
4.00 Afternoon Break & Poster Session
4:30 pm
Advancing RNA Therapeutics Development: Novel Reagents for DNA Template Production by Rolling Circle Amplification
5:30 pm
Panel Discussion – A European Industry & Regulatory Perspective on the Development & Approval of mRNA Medicines
6:20 pm
End of Conference Day One
Day Two
THURSDAY 13TH
7:00 am
7.00 Morning Coffee & Networking
7:50 am
Chair’s Opening Remarks
7:51 am
Advancing mRNA Vaccines & Therapies Towards the First Approval With Breaking First-InHuman Clinical Progress Data from Leaders in the Clinic
8:00 am
Safety, Tolerability, Pharmacokinetics & Target Engagement of ETH47 in Healthy Subjects
8:30 am
Technical & Clinical Progress in mRNA Therapeutics Beyond COVID-19 Vaccine
9:00 am
An mRNA Knowledge Library: Deep Profiling of Wild Type & Modified T7 Polymerases & Their Impacts on IVT Performance
9:30 am
9.30 Morning Networking Break
9:47 am
Turbocharging Antigen Selection & Design to Optimise mRNA Vaccine Safety & Tolerability for Emerging Infectious Diseases
9:47 am
Scale & Transfer – Leveraging Sustainable Platforms to Produce mRNA Products Effectively & Affordably for LMICs
10:00 am
Development of a Gonorrhea Vaccine Using the mRNA Platform Established at Afrigen
10:00 am
Techno-Economic Modelling for Sustainable, Low Cost & Scalable mRNA Medicines Manufacturing for LMICs
10:30 am
Session Reserved for: Immagina Biotechnology
10:30 am
Session Reserved for: Merck
11:00 am
Development of mRNA Vaccine Candidates for Pandemic Influenza
11:00 am
Towards Global Access & Equity for mRNA Technology: An Update from Afrigen Biologics
11:30 am
11.30 Lunch Break & Networking
12:29 pm
Achieving Effective Cell & Tissue Targeting, Distribution & Translatability with Novel LNP Formulations
12:30 pm
Development of a Diversity-Oriented Lipid Library to Fight Diseases
1:00 pm
OPPORTUNITY FOR PARTNERSHIP
1:28 pm
TRACK A: DISCOVERY & PRE-CLINICAL DEVELOPMENT
1:30 pm
Unlocking mRNA Therapies Through Spatial Delivery
2:00 pm
2.00 Afternoon Break & Networking
2:30 pm
Disruptive Companies Unlocking Diseases of Tomorrow With New Models Systems & Bioinformatic Approaches
2:35 pm
IL-35 mRNA Therapeutic Local Expression in the Liver Suppresses Autoimmune Hepatitis
3:00 pm
mRNA Therapeutic Vaccine Targeting Human IL-4 & IL-13 Protects Against Asthma
3:25 pm
A First-In-Class Technology for mRNA Delivery
4:00 pm
End of 4th mRNA-Based Therapeutics Summit Europe 2025
6:15 pm
Chair’s Closing Remarks
expect the best
This year's line up of speakers is even better than before. You'll hear from Brenda, Charlie, Bob, Tracy, Nicola, Shaz, Gillian, Simon, Carla, Stacy and Peter. We can't believe they all said they'd come back, but they have. And they'll all be there to share their ideas, tips and tricks with you.
Time Left Until The Conference Starts
Day
Hour
Minute
Second
14-17 December 2030, San Francisco